
Exploring the Disordered Regions of P53
Exploring the conformational landscapes of four intrinsically disordered regions.
Explore projectQuantum Pharmacy
Explore the biological questions and computational methods behind my work.
While much of the ordered protein machinery has been mapped, the Dark Proteome represents a significant challenge for targeted therapeutics.

Exploring the conformational landscapes of four intrinsically disordered regions.
Explore project
Investigating protein flexibility and interactions in p53 and Tau.
Explore projectInvestigating the origins of CHCHD2 amyloid fibril nucleation.
Explore projectMany proteins represent a complex challenge for scientists, as not even a natural ligand has been found. Complex challenges require elegant solutions.

Investigating potential binding partners and approaches to understanding NR2F6 recognition.
Explore project
Modeling peptide-inspired approaches to NR2F6–NSD1 interactions.
Explore project
Investigating an allosteric site in PXR and its relevance to pharmaceutical modeling.
Explore projectWhile small-molecule ligands are frequently tested in large quantities using HITS, peptidomimetics present a unique solution – hijacking biology itself.
Exploring new peptide-inspired approaches to pharmaceutical design.
Explore projectInvestigating which protein interactions to reproduce with peptidomimetics.
Explore projectExploring glycosylation sites as a consideration in peptidomimetic interaction design.
Explore projectDimensionality reduction, clustering, and NMR prediction provide tools for investigating molecular ensembles.

Dimensionality reduction and clustering for representative protein ensembles.
Explore project
Connecting molecular dynamics, fragmentation, and quantum chemical calculations.
Explore projectExploring how to better represent intrinsically disordered regions in molecular simulations.
Explore project